{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:30:27Z","timestamp":1790515827818,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.amjmed.2012.01.015","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T02:31:09Z","timestamp":1348021869000},"page":"991-999.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"title":["Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI Study"],"prefix":"10.1016","volume":"125","author":[{"given":"Guy","family":"Rostoker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Griuncelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Loridon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Couprie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbes","family":"Benmaadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bounhiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillippe","family":"Janklewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Drahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5 Suppl. 3","key":"10.1016\/j.amjmed.2012.01.015_bib1","first-page":"Sl6","article-title":"11. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.amjmed.2012.01.015_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of the anemia of end-stage renal disease with recombinant human erythropoietin","volume":"316","author":"Eschbach","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2012.01.015_bib3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1681\/ASN.2006080856","article-title":"Clinical aspects of iron use in the anemia of kidney disease","volume":"18","author":"H\u00f6rl","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2012.01.015_bib4","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2215\/CJN.01390406","article-title":"The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?","volume":"1","author":"Kalantar-Zadeh","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.amjmed.2012.01.015_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jama.1980.03310040025019","article-title":"Hemosiderosis in hemodialysis patients","volume":"244","author":"Ali","year":"1980","journal-title":"JAMA"},{"issue":"4-6","key":"10.1016\/j.amjmed.2012.01.015_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000181469","article-title":"Hemosiderosis secondary to chronic parenteral iron therapy in maintenance hemodialysis patients","volume":"22","author":"Pitts","year":"1978","journal-title":"Nephron"},{"issue":"191","key":"10.1016\/j.amjmed.2012.01.015_bib7","first-page":"369","article-title":"Iron metabolism in haemodialysis patients","volume":"48","author":"Gokal","year":"1979","journal-title":"Q J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2012.01.015_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1681\/ASN.2006101097","article-title":"Iron regulation","volume":"18","author":"Himmelfarb","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.amjmed.2012.01.015_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfn653","article-title":"Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP)","volume":"24","author":"Locatelli","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.amjmed.2012.01.015_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1525-139X.2007.00420.x","article-title":"Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines","volume":"21","author":"Fishbane","year":"2008","journal-title":"Semin Dial"},{"issue":"5","key":"10.1016\/j.amjmed.2012.01.015_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200008033430503","article-title":"Hepatic iron concentration and total body iron stores in thalassemia major","volume":"343","author":"Angelucci","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2012.01.015_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.blre.2008.03.001","article-title":"Current approach to hemochromatosis","volume":"22","author":"Brissot","year":"2008","journal-title":"Blood Rev"},{"issue":"8273","key":"10.1016\/j.amjmed.2012.01.015_bib13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0140-6736(82)92204-8","article-title":"Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy","volume":"1","author":"Ali","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2012.01.015_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/asheducation-2009.1.215","article-title":"Non-invasive assessment of tissue iron overload","author":"Fischer","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.amjmed.2012.01.015_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ejrad.2006.11.012","article-title":"Iron overload in the liver: diagnostic and quantification","volume":"61","author":"Alustiza","year":"2007","journal-title":"Eur J Radiol"},{"issue":"9406","key":"10.1016\/j.amjmed.2012.01.015_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(04)15436-6","article-title":"Non-invasive assessment of hepatic iron stores by MRI","volume":"363","author":"Gandon","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.amjmed.2012.01.015_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3324\/haematol.12413","article-title":"Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders","volume":"93","author":"Angelucci","year":"2008","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.amjmed.2012.01.015_bib18","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1523-1755.2004.00480.x","article-title":"Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients","volume":"65","author":"Canavese","year":"2004","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.amjmed.2012.01.015_bib19","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/j.1523-1755.2004.938_7.x","article-title":"Hepatic iron in hemodialysis patients","volume":"66","author":"Fishbane","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2012.01.015_bib20","series-title":"Traitement de l'an\u00e9mie au cours de l'insuffisance r\u00e9nale chronique de l'adulte","author":"Baumelou","year":"2005"},{"issue":"9045","key":"10.1016\/j.amjmed.2012.01.015_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0140-6736(96)06034-5","article-title":"A new syndrome of liver iron overload with normal transferrin saturation","volume":"349","author":"Moirand","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjmed.2012.01.015_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1525-1497.1998.00118.x","article-title":"Screening of problem drinking: comparison of CAGE and Audit","volume":"13","author":"Bradley","year":"1998","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.amjmed.2012.01.015_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.2009.413","article-title":"An improved comorbidity index for outcome analyses among dialysis patients","volume":"77","author":"Liu","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2012.01.015_bib24","series-title":"Handbook of Parametric and Nonparametric Statistical Procedures","author":"Sheskin","year":"2007"},{"key":"10.1016\/j.amjmed.2012.01.015_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2215\/CJN.04190510","article-title":"Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease","volume":"6","author":"Ferrari","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.amjmed.2012.01.015_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1542-4758.2009.00378.x","article-title":"Hemochromatosis gene mutations and treatment of anemia in patients on hemodialysis","volume":"13","author":"Brown","year":"2009","journal-title":"Hemodialysis Int"},{"issue":"1","key":"10.1016\/j.amjmed.2012.01.015_bib27","first-page":"77","article-title":"Secondary iron overload disorders","volume":"35","author":"Bottomley","year":"1998","journal-title":"Semin Hematol"},{"key":"10.1016\/j.amjmed.2012.01.015_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000068487","article-title":"High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: the Budapest Study on 50 patients","volume":"109","author":"V\u00e1rkonyi","year":"2003","journal-title":"Acta Haematol"},{"key":"10.1016\/j.amjmed.2012.01.015_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2141.2006.06277.x","article-title":"Oxydative stress and inflammation in iron-overload patients with beta-thalassemia or sickle cell disease","volume":"135","author":"Walter","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2012.01.015_bib30","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ajh.21456","article-title":"Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease","volume":"84","author":"Ghugre","year":"2009","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.amjmed.2012.01.015_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12185-008-0120-5","article-title":"Body iron metabolism and pathophysiology of iron overload","volume":"88","author":"Kohgo","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.amjmed.2012.01.015_bib32","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0735-1097(02)02611-6","article-title":"Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis","volume":"40","author":"Gaenzer","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2012.01.015_bib33","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","article-title":"Iron therapy, advanced oxidation protein products and carotid artery intima-media thickness in end-stage renal disease","volume":"106","author":"Dr\u00fceke","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2012.01.015_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1536\/ihj.46.255","article-title":"Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease","volume":"46","author":"Reis","year":"2005","journal-title":"Int Heart J"},{"key":"10.1016\/j.amjmed.2012.01.015_bib35","article-title":"Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD","author":"Van Buren","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.amjmed.2012.01.015_bib36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2215\/CJN.03850808","article-title":"Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients","volume":"4","author":"Ibrahim","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2012.01.015_bib37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrneph.2010.139","article-title":"Iron supplementation to treat anemia in patients with chronic kidney disease","volume":"6","author":"Besarab","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.amjmed.2012.01.015_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1492-7535.2005.01116.x","article-title":"Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation","volume":"9","author":"Morena","year":"2005","journal-title":"Hemodial Int"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934312000927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934312000927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:59:01Z","timestamp":1757581141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934312000927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0002934312000927"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2012.01.015","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2012.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}